Grant: Planning and Dissemination Grant - Institute Community Support
Direct Payment
$15,000.00
Best Practices for Randomized Controlled Studies on the Effects of Whole Foods: Establishing evidence in support of Canadian Agri-Food products
FY 2018-19
Summary
When positioning foods to consumers, the use of front-of-package claims provides important messaging that can describe the beneficial health effects associated with the consumption of specific foods or derived food ingredients. Health claims on foods are specific statements, regulated by Health Canada, that are designed to convey evidence-based relationships between food/food component consumption and public health. These claims are often the most powerful tools to provide health-related messaging to consumers on the role of specific foods, including statements related to disease-reduction. Supporting data for health claims on foods must be based on high-quality, non-biased human clinical studies, with randomized controlled studies providing the highest level of evidence. A challenge exists when designing and executing RCTs investigating the linkage between whole food consumption and a specific biological impact linked to nutrition-related chronic diseases (ie: change in blood cholesterol; change in blood pressure; change in blood glucose concentrations). In drug studies, it is easy to provide a placebo and to blind participants to the treatment (ie: same colour capsule containing an inert agent), and these attributes are key for standard RCT studies. For whole foods (ie: eggs, fish, whole grains, blueberries, etc...), it is often not possible to provide an appropriate placebo, nor is it possible to adequately "blind" participants to the foods they are consuming. As a result, whole food RCTs tend to be discounted by regulatory bodies due to inadequate design. This is a waste of time, money and resources. There is a need to develop "Best Practices for the Design and Implementation of RCTs involving Whole Foods to Substantiate Health Claims". This effort would guide commodity groups and the broader food industry in the development and implementation of studies designed to improve the marketability and consumption of Canadian agri-food products.
Department
Program
Planning and Dissemination Grant - Institute Community Support
Recipient
Location
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
392092
Name
Grantham Andrea
Region
Ontario
Country
Canada
Orgtype
Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Planning and Dissemination - INMD
Projecttitle
Best Practices for Randomized Controlled Studies on the Effects of Whole Foods: Establishing evidence in support of Canadian Agri-Food products
Programtype2
Miscellaneous Programs
Orgnameinp2
Direct Payment
Cihramount2
$15,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Agri-Food; Best Practices; Health Claims; Knowledge Translation; Nutrient-Related Chronic Disease; Nutrition Messaging; Placebo; Randomized Controlled Studies; Whole Food Studies; Workshop
Abstract
When positioning foods to consumers, the use of front-of-package claims provides important messaging that can describe the beneficial health effects associated with the consumption of specific foods or derived food ingredients. Health claims on foods are specific statements, regulated by Health Canada, that are designed to convey evidence-based relationships between food/food component consumption and public health. These claims are often the most powerful tools to provide health-related messaging to consumers on the role of specific foods, including statements related to disease-reduction. Supporting data for health claims on foods must be based on high-quality, non-biased human clinical studies, with randomized controlled studies providing the highest level of evidence. A challenge exists when designing and executing RCTs investigating the linkage between whole food consumption and a specific biological impact linked to nutrition-related chronic diseases (ie: change in blood cholesterol; change in blood pressure; change in blood glucose concentrations). In drug studies, it is easy to provide a placebo and to blind participants to the treatment (ie: same colour capsule containing an inert agent), and these attributes are key for standard RCT studies. For whole foods (ie: eggs, fish, whole grains, blueberries, etc...), it is often not possible to provide an appropriate placebo, nor is it possible to adequately "blind" participants to the foods they are consuming. As a result, whole food RCTs tend to be discounted by regulatory bodies due to inadequate design. This is a waste of time, money and resources. There is a need to develop "Best Practices for the Design and Implementation of RCTs involving Whole Foods to Substantiate Health Claims". This effort would guide commodity groups and the broader food industry in the development and implementation of studies designed to improve the marketability and consumption of Canadian agri-food products.
Competitiondate
201809
Approvedterm2
1 yr 0 mth
Pinamesdelim
Grantham, Andrea
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $15,000~ $0~